Advertisement

Morphological Basis of Persistent Bowel Problems Following a Properly Performed Pull-Through Operation for Hirschsprung’s Disease

  • David Coyle
  • Prem PuriEmail author
Chapter

Abstract

Despite having a technically satisfactory pull-through operation for Hirschsprung’s disease (HSCR) (complete resection of all aganglionic or hypoganglionic colon with hypertrophic nerve trunks while avoiding injury to the sphincter mechanism), a substantial proportion of patients continue to experience symptoms such as intractable constipation, soiling, or recurrent Hirschsprung-associated enterocolitis. Some of these patients are later found to have a retained segment of aganglionic or transition zone colon. This may be avoided with more rigorous definition of what constitutes transition zone colon and by ensuring that a margin, the recommended length of which has yet to be determined, of colon above the normally ganglionated intraoperative biopsy is also resected.

The ostensibly normal ganglionic colon in children with HSCR exhibits a range of abnormalities when compared to healthy colon from children without HSCR. Excitatory and inhibitory innervation is imbalanced, with excessive nitrergic innervation and deficient cholinergic innervation (the opposite of what is seen in aganglionic colon). Neuronal serotonin, which has an anti-inflammatory role, is deficient in the ganglionic colon, especially of those who have been treated for enterocolitis.

The support cells responsible for intercellular communication in the electrical syncytium composed of the colonic smooth muscle and the enteric nervous system is also deficient, with less dense networks of interstitial cells of Cajal (ICC) (the pacemaker cells of the colon) and PDGFRα+ cells (mediate smooth muscle relaxation) being observed.

Finally, the colonic microbiome in children with HSCR is less diverse than that seen in healthy children, with expansions of pathogenic organisms and Candida species. This occurs in association with deficiency of mucus-producing goblet cells and other abnormalities of innate immunity and may contribute toward the increased susceptibility for Hirschsprung-associated enterocolitis seen in some patients after pull-through surgery.

Keywords

Hirschsprung’s disease Transition zone pull-through 

References

  1. 1.
    Haricharan RN, Georgeson KE. Hirschsprung disease. Semin Pediatr Surg. 2008;17(4):266–75.  https://doi.org/10.1053/j.sempedsurg.2008.07.005.CrossRefPubMedGoogle Scholar
  2. 2.
    Dasgupta R, Langer JC. Hirschsprung disease. Curr Probl Surg. 2004;41(12):942–88.  https://doi.org/10.1067/j.cpsurg.2004.09.004.CrossRefPubMedGoogle Scholar
  3. 3.
    Rintala RJ, Pakarinen MP. Long-term outcomes of Hirschsprung disease. Semin Pediatr Surg. 2012;21(4):336–43.  https://doi.org/10.1053/j.sempedsurg.2012.07.008.CrossRefPubMedGoogle Scholar
  4. 4.
    Langer JC. Persistent obstructive symptoms after surgery for Hirschsprung disease: development of a diagnostic and therapeutic algorithm. J Pediatr Surg. 2004;39(10):1458–62.CrossRefGoogle Scholar
  5. 5.
    Levitt MA, Dickie B, Pena A. Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. Semin Pediatr Surg. 2010;19(2):146–53.  https://doi.org/10.1053/j.sempedsurg.2009.11.013.CrossRefPubMedGoogle Scholar
  6. 6.
    Chumpitazi BP, Nurko S. Defecation disorders in children after surgery for Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2011;53(1):75–9.  https://doi.org/10.1097/MPG.0b013e318212eb53. PubMed PMID: 21694540CrossRefGoogle Scholar
  7. 7.
    Zakaria OM. Bowel function and fecal continence after Soave’s trans-anal endorectal pull-through for Hirschsprung disease: a local experience. Updat Surg. 2012;64(2):113–8.  https://doi.org/10.1007/s13304-012-0140-9. PubMed PMID: 22392576CrossRefGoogle Scholar
  8. 8.
    Thomson D, Allin B, Long AM, Bradnock T, Walker G, Knight M. Laparoscopic assistance for primary transanal pull-through in Hirschsprung disease: a systematic review and meta-analysis. BMJ Open. 2015;5(3):e006063.  https://doi.org/10.1136/bmjopen-2014-006063. PubMed PMID: 25805527; PubMed Central PMCID: PMCPMC4386272CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kim AC, Langer JC, Pastor AC, Zhang L, Sloots CE, Hamilton NA, et al. Endorectal pull-through for Hirschsprung disease-a multicenter, long-term comparison of results: transanal vs transabdominal approach. J Pediatr Surg. 2010;45(6):1213–20.  https://doi.org/10.1016/j.jpedsurg.2010.02.087. PubMed PMID: 20620323CrossRefPubMedGoogle Scholar
  10. 10.
    Nasr A, Haricharan RN, Gamarnik J, Langer JC. Transanal pullthrough for Hirschsprung disease: matched case-control comparison of soave and Swenson techniques. J Pediatr Surg. 2014;49(5):774–6.  https://doi.org/10.1016/j.jpedsurg.2014.02.073. PubMed PMID: 24851768CrossRefPubMedGoogle Scholar
  11. 11.
    Zhang SC, Bai YZ, Wang W, Wang WL. Long-term outcome, colonic motility, and sphincter performance after Swenson’s procedure for Hirschsprung disease: a single-center 2-decade experience with 346 cases. Am J Surg. 2007;194(1):40–7.  https://doi.org/10.1016/j.amjsurg.2006.10.018. PubMed PMID: 17560907CrossRefPubMedGoogle Scholar
  12. 12.
    Granstrom AL, Husberg B, Nordenskjold A, Svensson PJ, Wester T. Laparoscopic-assisted pull-through for Hirschsprung disease, a prospective repeated evaluation of functional outcome. J Pediatr Surg. 2013;48(12):2536–9.  https://doi.org/10.1016/j.jpedsurg.2013.07.017. PubMed PMID: 24314199CrossRefPubMedGoogle Scholar
  13. 13.
    Frykman PK, Short SS. Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg. 2012;21(4):328–35.  https://doi.org/10.1053/j.sempedsurg.2012.07.007. PubMed PMID: 22985838; PubMed Central PMCID: PMC3462485CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Austin KM. The pathogenesis of Hirschsprung disease-associated enterocolitis. Semin Pediatr Surg. 2012;21(4):319–27.  https://doi.org/10.1053/j.sempedsurg.2012.07.006. PubMed PMID: 22985837CrossRefPubMedGoogle Scholar
  15. 15.
    Engum SA, Grosfeld JL. Long-term results of treatment of Hirschsprung disease. Semin Pediatr Surg. 2004;13(4):273–85. PubMed PMID: 15660321CrossRefGoogle Scholar
  16. 16.
    Mills JL, Konkin DE, Milner R, Penner JG, Langer M, Webber EM. Long-term bowel function and quality of life in children with Hirschsprung disease. J Pediatr Surg. 2008;43(5):899–905.  https://doi.org/10.1016/j.jpedsurg.2007.12.038. PubMed PMID: 18485963CrossRefPubMedGoogle Scholar
  17. 17.
    Kapur RP, Kennedy AJ. Transitional zone pull through: surgical pathology considerations. Semin Pediatr Surg. 2012;21(4):291–301.  https://doi.org/10.1053/j.sempedsurg.2012.07.003. PubMed PMID: 22985834CrossRefGoogle Scholar
  18. 18.
    Das K, Kini U, Babu MK, Mohanty S, D’Cruz AJ. The distal level of normally innervated bowel in long segment colonic Hirschsprung disease. Pediatr Surg Int. 2010;26(6):593–9.  https://doi.org/10.1007/s00383-010-2603-8. PubMed PMID: 20419377CrossRefPubMedGoogle Scholar
  19. 19.
    Jamieson DH, Dundas SE, Belushi SA, Cooper M, Blair GK. Does the transition zone reliably delineate aganglionic bowel in Hirschsprung disease? Pediatr Radiol. 2004;34(10):811–5.  https://doi.org/10.1007/s00247-004-1292-7. PubMed PMID: 15278325CrossRefPubMedGoogle Scholar
  20. 20.
    Schappi MG, Staiano A, Milla PJ, Smith VV, Dias JA, Heuschkel R, et al. A practical guide for the diagnosis of primary enteric nervous system disorders. J Pediatr Gastroenterol Nutr. 2013;57(5):677–86.  https://doi.org/10.1097/MPG.0b013e3182a8bb50. PubMed PMID: 24177787CrossRefPubMedGoogle Scholar
  21. 21.
    Frongia G, Gunther P, Schenk JP, Strube K, Kessler M, Mehrabi A, et al. Contrast enema for Hirschsprung disease investigation: diagnostic accuracy and validity for subsequent diagnostic and surgical planning. Eur J Pediatr Surg. 2015;26:207.  https://doi.org/10.1055/s-0035-1546755. PubMed PMID: 25803244CrossRefPubMedGoogle Scholar
  22. 22.
    Muller CO, Mignot C, Belarbi N, Berrebi D, Bonnard A. Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung disease? Pediatr Surg Int. 2012;28(6):597–601.  https://doi.org/10.1007/s00383-012-3094-6. PubMed PMID: 22534881CrossRefPubMedGoogle Scholar
  23. 23.
    Lawal TA, Chatoorgoon K, Collins MH, Coe A, Pena A, Redo LMA. Pull-through in Hirschsprung [corrected] disease for obstructive symptoms due to residual aganglionosis and transition zone bowel. J Pediatr Surg. 2011;46(2):342–7.  https://doi.org/10.1016/j.jpedsurg.2010.11.014. PubMed PMID: 21292085CrossRefGoogle Scholar
  24. 24.
    White FV, Langer JC. Circumferential distribution of ganglion cells in the transition zone of children with Hirschsprung disease. Pediatr Dev Pathol. 2000;3(3):216–22. PubMed PMID: 10742408CrossRefGoogle Scholar
  25. 25.
    Swaminathan M, Kapur RP. Counting myenteric ganglion cells in histologic sections: an empirical approach. Hum Pathol. 2010;41(8):1097–108.  https://doi.org/10.1016/j.humpath.2009.12.012. PubMed PMID: 20346481CrossRefGoogle Scholar
  26. 26.
    Kapur RP, Kennedy AJ. Histopathologic delineation of the transition zone in short-segment Hirschsprung disease. Pediatr Dev Pathol. 2013;16(4):252–66.  https://doi.org/10.2350/12-12-1282-OA.1. PubMed PMID: 23495711CrossRefGoogle Scholar
  27. 27.
    Kapur RP. Histology of the transition zone in Hirschsprung disease. Am J Surg Pathol. 2016;40:1637.  https://doi.org/10.1097/PAS.0000000000000711. PubMed PMID: 27526297CrossRefGoogle Scholar
  28. 28.
    Georgeson KE. Laparoscopic-assisted pull-through for Hirschsprung disease. Semin Pediatr Surg. 2002;11(4):205–10. PubMed PMID: 12407501CrossRefGoogle Scholar
  29. 29.
    Kenny SE, Tam PK, Garcia-Barcelo M. Hirschsprung disease. Semin Pediatr Surg. 2010;19(3):194–200.  https://doi.org/10.1053/j.sempedsurg.2010.03.004. PubMed PMID: 20610192CrossRefPubMedGoogle Scholar
  30. 30.
    Koh SD, Rhee PL. Ionic conductance(s) in response to post-junctional potentials. J Neurogastroenterol Motility. 2013;19(4):426–32.  https://doi.org/10.5056/jnm.2013.19.4.426. PubMed PMID: 24199003; PubMed Central PMCID: PMC3816177CrossRefGoogle Scholar
  31. 31.
    O’Kelly TJ, Davies JR, Tam PK, Brading AF, Mortensen NJ. Abnormalities of nitric-oxide-producing neurons in Hirschsprung disease: morphology and implications. J Pediatr Surg. 1994;29(2):294–9; discussion 9–300 PubMed PMID: 7513759CrossRefGoogle Scholar
  32. 32.
    Sandgren K, Larsson LT, Ekblad E. Widespread changes in neurotransmitter expression and number of enteric neurons and interstitial cells of Cajal in lethal spotted mice: an explanation for persisting dysmotility after operation for Hirschsprung disease? Dig Dis Sci. 2002;47(5):1049–64. PubMed PMID: 12018900CrossRefGoogle Scholar
  33. 33.
    Zaitoun I, Erickson CS, Barlow AJ, Klein TR, Heneghan AF, Pierre JF, et al. Altered neuronal density and neurotransmitter expression in the ganglionated region of Ednrb null mice: implications for Hirschsprung disease. Neurogastroenterol Motil. 2013;25(3):e233–44.  https://doi.org/10.1111/nmo.12083. PubMed PMID: 23360229; PubMed Central PMCID: PMC3578114CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Coyle D, O’Donnell AM, Gillick J, Puri P. Altered neurotransmitter expression profile in the ganglionic bowel in Hirschsprung disease. J Pediatr Surg. 2016;51(5):762–9.  https://doi.org/10.1016/j.jpedsurg.2016.02.018. PubMed PMID: 26951962CrossRefPubMedGoogle Scholar
  35. 35.
    Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung disease. Pediatr Surg Int. 2006;22(4):316–8.  https://doi.org/10.1007/s00383-006-1639-2. PubMed PMID: 16463033CrossRefPubMedGoogle Scholar
  36. 36.
    Pastor AC, Osman F, Teitelbaum DH, Caty MG, Langer JC. Development of a standardized definition for Hirschsprung-associated enterocolitis: a Delphi analysis. J Pediatr Surg. 2009;44(1):251–6.  https://doi.org/10.1016/j.jpedsurg.2008.10.052. PubMed PMID: 19159752CrossRefPubMedGoogle Scholar
  37. 37.
    Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14–21.  https://doi.org/10.1097/MED.0b013e32835bc703. PubMed PMID: 23222853; PubMed Central PMCID: PMC3708472CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Gershon MD. Enteric serotonergic neurones ... Finally! J Physiol. 2009;587(Pt 3):507.  https://doi.org/10.1113/jphysiol.2008.167676. PubMed PMID: 19182271; PubMed Central PMCID: PMC2670073CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Gershon MD. Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans Am Clin Climatol Assoc. 2012;123:268–80. discussion 80. PubMed PMID: 23303993; PubMed Central PMCID: PMC3540639PubMedPubMedCentralGoogle Scholar
  40. 40.
    Mawe GM, Hoffman JM. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473–86.  https://doi.org/10.1038/nrgastro.2013.105. PubMed PMID: 23797870; PubMed Central PMCID: PMC4048923CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Galligan JJ. 5-hydroxytryptamine, ulcerative colitis, and irritable bowel syndrome: molecular connections. Gastroenterology. 2004;126(7):1897–9. PubMed PMID: 15188186CrossRefGoogle Scholar
  42. 42.
    Soeda J, O’Briain DS, Puri P. Regional reduction in intestinal neuroendocrine cell populations in enterocolitis complicating Hirschsprung disease. J Pediatr Surg. 1993;28(8):1063–8. PubMed PMID: 7901360CrossRefGoogle Scholar
  43. 43.
    Okamoto T, Barton MJ, Hennig GW, Birch GC, Grainger N, Corrigan RD, et al. Extensive projections of myenteric serotonergic neurons suggest they comprise the central processing unit in the colon. Neurogastroenterol Motil. 2014;26(4):556–70.  https://doi.org/10.1111/nmo.12302. PubMed PMID: 24460867CrossRefPubMedGoogle Scholar
  44. 44.
    Smith TK, Park KJ, Hennig GW. Colonic migrating motor complexes, high amplitude propagating contractions, neural reflexes and the importance of neuronal and mucosal serotonin. J Neurogastroenterol Motility. 2014;20(4):423–46.  https://doi.org/10.5056/jnm14092. PubMed PMID: 25273115; PubMed Central PMCID: PMC4204412CrossRefGoogle Scholar
  45. 45.
    Coyle D, Murphy JM, Doyle B, O’Donnell AM, Gillick J, Puri P. Altered tryptophan hydroxylase 2 expression in enteric serotonergic nerves in Hirschsprung-associated enterocolitis. World J Gastroenterol. 2016;22(19):4662–72.  https://doi.org/10.3748/wjg.v22.i19.4662. PubMed PMID: 27217698; PubMed Central PMCID: PMCPMC4870073CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Sanders KM. Rhythmic electrical activity and regulation of gut motility. Eur Rev Med Pharmacol Sci. 2008;12(Suppl 1):129–31. PubMed PMID: 18924452PubMedGoogle Scholar
  47. 47.
    Baker SA, Mutafova-Yambolieva V, Monaghan K, Horowitz B, Sanders KM, Koh SD. Mechanism of active repolarization of inhibitory junction potential in murine colon. Am J Physiol Gastrointest Liver Physiol. 2003;285(5):G813–21.  https://doi.org/10.1152/ajpgi.00115.2003. PubMed PMID: 14561587CrossRefPubMedGoogle Scholar
  48. 48.
    Peri LE, Sanders KM, Mutafova-Yambolieva VN. Differential expression of genes related to purinergic signaling in smooth muscle cells, PDGFRalpha-positive cells, and interstitial cells of Cajal in the murine colon. Neurogastroenterol Motil. 2013;25(9):e609–20.  https://doi.org/10.1111/nmo.12174. PubMed PMID: 23809506; PubMed Central PMCID: PMC3735650CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Benarroch EE. Enteric nervous system: functional organization and neurologic implications. Neurology. 2007;69(20):1953–7.  https://doi.org/10.1212/01.wnl.0000281999.56102.b5. PubMed PMID: 17998487CrossRefPubMedGoogle Scholar
  50. 50.
    Burns AJ. Disorders of interstitial cells of Cajal. J Pediatr Gastroenterol Nutr. 2007;45(Suppl 2):S103–6.  https://doi.org/10.1097/MPG.0b013e31812e65e0. PubMed PMID: 18185068CrossRefGoogle Scholar
  51. 51.
    Coyle D, Kelly DA, O’Donnell AM, Gillick J, Puri P. Use of anoctamin 1 (ANO1) to evaluate interstitial cells of Cajal in Hirschsprung disease. Pediatr Surg Int. 2016;32(2):125–33.  https://doi.org/10.1007/s00383-015-3822-9. PubMed PMID: 26510736CrossRefGoogle Scholar
  52. 52.
    Taguchi T, Suita S, Masumoto K, Nagasaki A. An abnormal distribution of C-kit positive cells in the normoganglionic segment can predict a poor clinical outcome in patients with Hirschsprung disease. Eur J Pediatr Surg. 2005;15(3):153–8.  https://doi.org/10.1055/s-2005-837612. PubMed PMID: 15999306CrossRefPubMedGoogle Scholar
  53. 53.
    O’Donnell AM, Coyle D, Puri P. Deficiency of platelet-derived growth factor receptor-alpha-positive cells in Hirschsprung disease colon. World J Gastroenterol. 2016;22(12):3335–40.  https://doi.org/10.3748/wjg.v22.i12.3335. PubMed PMID: 27022215; PubMed Central PMCID: PMCPMC4806191CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Coyle D, O’Donnell AM, Puri P. Altered distribution of small-conductance calcium-activated potassium channel SK3 in Hirschsprung disease. J Pediatr Surg. 2015;50(10):1659–64.  https://doi.org/10.1016/j.jpedsurg.2015.01.013. PubMed PMID: 25783396CrossRefPubMedGoogle Scholar
  55. 55.
    Coyle D, Doyle B, Murphy JM, O’Donnell AM, Gillick J, Puri P. Expression of connexin 26 and connexin 43 is reduced in Hirschsprung disease. J Surg Res. 2016;206(1):242–51.  https://doi.org/10.1016/j.jss.2016.08.010. PubMed PMID: 27916369CrossRefGoogle Scholar
  56. 56.
    Nemeth L, Maddur S, Puri P. Immunolocalization of the gap junction protein Connexin43 in the interstitial cells of Cajal in the normal and Hirschsprung disease bowel. J Pediatr Surg. 2000;35(6):823–8.  https://doi.org/10.1053/jpsu.2000.6851. PubMed PMID: 10873019CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    O’Donnell AM, Coyle D, Puri P. Decreased expression of Kv7 channels in Hirchsprung’s disease. J Pediatr Surg. 2017;52(7):1177–81.  https://doi.org/10.1016/j.jpedsurg.2016.12.028. PubMed PMID: 28087137CrossRefPubMedGoogle Scholar
  58. 58.
    O’Donnell AM, Coyle D, Puri P. Decreased Nav1.9 channel expression in Hirschsprung disease. J Pediatr Surg. 2016;51(9):1458–61.  https://doi.org/10.1016/j.jpedsurg.2016.05.007. PubMed PMID: 27297039CrossRefPubMedGoogle Scholar
  59. 59.
    Frykman PK, Kim S, Wester T, Nordenskjold A, Kawaguchi A, Hui TT, et al. Critical evaluation of the Hirschsprung-associated enterocolitis (HAEC) score: a multicenter study of 116 children with Hirschsprung disease. J Pediatr Surg. 2018;53(4):708–17.  https://doi.org/10.1016/j.jpedsurg.2017.07.009. PubMed PMID: 28760457CrossRefPubMedGoogle Scholar
  60. 60.
    Gosain A, Brinkman AS. Hirschsprung associated enterocolitis. Curr Opin Pediatr. 2015;27(3):364–9.  https://doi.org/10.1097/MOP.0000000000000210. PubMed PMID: 25944307; PubMed Central PMCID: PMCPMC4451822CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Neuvonen MI, Korpela K, Kyrklund K, Rintala RJ, Pakarinen MP. Intestinal microbiota in Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2018;67:594.  https://doi.org/10.1097/MPG.0000000000001999. PubMed PMID: 29652728CrossRefGoogle Scholar
  62. 62.
    Frykman PK, Nordenskjold A, Kawaguchi A, Hui TT, Granstrom AL, Cheng Z, et al. Characterization of bacterial and fungal microbiome in children with Hirschsprung disease with and without a history of Enterocolitis: a multicenter study. PLoS One. 2015;10(4):e0124172.  https://doi.org/10.1371/journal.pone.0124172. PubMed PMID: 25909773; PubMed Central PMCID: PMCPMC4409062CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Li Y, Poroyko V, Yan Z, Pan L, Feng Y, Zhao P, et al. Characterization of intestinal microbiomes of Hirschsprung disease patients with or without Enterocolitis using Illumina-MiSeq high-throughput sequencing. PLoS One. 2016;11(9):e0162079.  https://doi.org/10.1371/journal.pone.0162079. PubMed PMID: 27603009; PubMed Central PMCID: PMCPMC5014423 CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Tomuschat C, O’Donnell AM, Coyle D, Dreher N, Kelly D, Puri P. Altered expression of a two-pore domain (K2P) mechano-gated potassium channel TREK-1 in Hirschsprung disease. Pediatr Res. 2016;80(5):729–33.  https://doi.org/10.1038/pr.2016.140. PubMed PMID: 27384506CrossRefGoogle Scholar
  65. 65.
    Nakamura H, Tomuschat C, Coyle D, O’Donnel AM, Lim T, Puri P. Altered goblet cell function in Hirschsprung disease. Pediatr Surg Int. 2018;34(2):121–8.  https://doi.org/10.1007/s00383-017-4178-0. PubMed PMID: 29383490CrossRefGoogle Scholar
  66. 66.
    Tomuschat C, O’Donnell AM, Coyle D, Puri P. Altered expression of IL36gamma and IL36 receptor (IL1RL2) in the colon of patients with Hirschsprung disease. Pediatr Surg Int. 2017;33(2):181–6.  https://doi.org/10.1007/s00383-016-4011-1. PubMed PMID: 27853811CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Temple Street Children’s University HospitalDublinIreland
  2. 2.National Children’s Research Centre, Our Lady’s Children’s Hospital, CrumlinDublinIreland

Personalised recommendations